Acute Myeloid Leukemia in the Elderly Patient: New Strategies.

ABSTRACT: Although selected older adults with acute myeloid leukemia can benefit from intensive therapies, recent evidences support the use of lower-intensity therapies (hypomethylating agents or low-dose cytarabine) in most of these patients and emphasize the importance of tolerability and quality of life. Individualized approaches to treatment decision-making beyond consideration of chronologic age alone should therefore be considered. One promising strategy is to combine low-intensity treatments with novel agents.

SUBMITTER: Thomas X 

PROVIDER: S-EPMC4837938 | biostudies-literature |

REPOSITORIES: biostudies-literature